Eduardo Mysler

Medicine · Health Sciences

40h-index18.9kcitations162works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(99), Autoimmune and Inflammatory Disorders Research(53), Systemic Lupus Erythematosus Research(50), Biosimilars and Bioanalytical Methods(34), Lymphoma Diagnosis and Treatment(26)

Publications160 total

Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis
Rheumatology and Therapy·2026Open Access
Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review
EULAR Rheumatology Open·2026
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment
Annals of the Rheumatic Diseases·2025Open Access
Correction: Long-term persistence of biological agents in the treatment of patients with rheumatoid arthritis: a systematic literature review and meta-analysis
Clinical Rheumatology·2025Open Access
Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials
BMJ Open·2025· 1 citedOpen Access
Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis
The Lancet Rheumatology·2025
Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial
RMD Open·2025Open Access
Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy
RMD Open·2025· 2 citedOpen Access
POS0540 Long-Term Safety and Efficacy of Upadacitinib or Adalimumab in Patients With Rheumatoid Arthritis: 7-Year Data From the SELECT-COMPARE Study
Annals of the Rheumatic Diseases·2025Open Access
POS1097 Long-Term Safety of Upadacitinib Across Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis Encompassing ~17,000 Patient-Years of Clinical Trial Data
Annals of the Rheumatic Diseases·2025Open Access
CAPÍTULO 4: Algoritmo de tratamiento sugerido para pacientes con artritis reumatoidea
Revista Argentina de Reumatología·2025Open Access
CAPÍTULO 3: Consenso en temas de interés general relacionados con el tratamiento de la artritis reumatoidea
Revista Argentina de Reumatología·2025Open Access
CAPÍTULO 2: Manejo terapéutico en pacientes con artritis reumatoidea
Revista Argentina de Reumatología·2025Open Access
Benefit–risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease
RMD Open·2025· 2 citedOpen Access
A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
Rheumatology and Therapy·2025Open Access
Long-Term Safety and Efficacy of Upadacitinib or Adalimumab in Patients With Rheumatoid Arthritis: 7-Year Data From the SELECT-COMPARE Study
2025
Current smoking is related to severe damage in systemic lupus erythematosus patients
Lupus·2024· 1 cited
Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities
Kidney International Reports·2024· 5 citedOpen Access
Rheumatoid arthritis in Latin America: pharmacotherapy and clinical challenges
Expert Opinion on Pharmacotherapy·2024· 6 cited
Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
Rheumatology and Therapy·2024· 2 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Gerd R Burmester(11), Peter Nash(9), Roy Fleischmann(9), Andrea Rubbert‐Roth(7), Robert J. Moots(7), Mark C. Genovese(6), Patrick Durez(6), Iain B. McInnes(5), Tsutomu Takeuchi(5), Gyula Poór(4), Désirée van der Heijde(4), Josef S Smolen(4), Cătălin Codreanu(4), Kevin Winthrop(4), David Jayne(4), Gerhard Krammer(4), Stephen Hall(4), Rieke Alten(4), Yoshiya Tanaka(4), Valderílio Feijó Azevedo(4)